Drug Shortage Report for SANDOZ FLUOXETINE
Report ID | 125639 |
Drug Identification Number | 02479486 |
Brand name | SANDOZ FLUOXETINE |
Common or Proper name | SANDOZ FLUOXETINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FLUOXETINE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100HGC BO V1 CA |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-10-02 |
Estimated end date | 2020-10-09 |
Actual end date | 2020-10-09 |
Shortage status | Resolved |
Updated date | 2020-10-13 |
Company comments | Delay in the release of the drug |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-10-13 | French | Compare |
v3 | 2020-10-13 | English | Compare |
v2 | 2020-10-05 | French | Compare |
v1 | 2020-10-05 | English | Compare |
Showing 1 to 4 of 4